August 19, 2024 — D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software and services, and the first commercial provider of quantum computers, has announced a significant expansion of its Leap quantum cloud service, targeting advancements in artificial intelligence (“AI”) and machine learning (“ML”). The newly revealed roadmap outlines strategic initiatives aimed at integrating quantum computing with […]
August 19, 2024 — D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software and services, and the first commercial provider of quantum computers, has announced a significant expansion of its Leap quantum cloud service, targeting advancements in artificial intelligence (“AI”) and machine learning (“ML”). The newly revealed roadmap outlines strategic initiatives aimed at integrating quantum computing with […]
August 16, 2024 — Annovis Bio (NYSE: ANVS), a late-stage, drug-platform company developing novel therapies for neurodegenerative diseases such as Alzheimer’s (“AD”) and Parkinson’s disease (“PD”), today released financial results for its second quarter ended June 30, 2024, and provided a business update. According to the update, results from the company’s completed Phase 2/3 AD study showed that buntanetap significantly […]
August 16, 2024 — HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through the power of personalized insights, is reporting on financial and operations results for its second quarter 2024, the period that ended June 30, 2024. Highlights of the report include steady progress made toward key clinical and regulatory milestones on its HeartBeam AIMIGo(TM) System, […]
August 16, 2024 — CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today released its financial results for the second quarter ended June 30, 2024 (“Q2 2024”). The company also discussed the clinical development progress of Berubicin, its lead program, and TPI 287, […]
August 16, 2024 — Scinai Immunotherapeutics (NASDAQ: SCNI) is a biopharmaceutical company focused on developing inflammation and immunology (“I&I”) biological products and providing CDMO services through its Scinai Bioservices business unit. The company today published its financial results for the second quarter ended June 30, 2024, and provided a business update. Scinai plans to host a webinar to discuss its […]
August 15, 2024 — Annovis Bio (NYSE: ANVS), a late-stage clinical drug platform company, announced new preclinical data demonstrating lead compound buntanetap’s potential to synergistically enhance cognition when used in combination with the glucagon-like peptide 1 (GLP-1) agonist dulaglutide (Trulicity(R)) in a mouse model of Alzheimer’s disease (https://ibn.fm/9WpKW). GLP-1 agonists, such as dulaglutide, are known for their ability to […]
August 15, 2024 — McEwen Mining (NYSE: MUX) (TSX: MUX) is an asset-rich diversified gold and silver producer in the Americas. McEwen CEO Rob McEwen recently spoke at the NYC SME’s 9th Annual Current Trends in Mining Finance Conference, where he emphasized the crucial importance of the mining industry to modern civilization and outlined a strategic approach to improving […]
August 15, 2024 — McEwen Mining (NYSE: MUX) (TSX: MUX) is an asset-rich diversified gold and silver producer in the Americas. McEwen CEO Rob McEwen recently spoke at the NYC SME’s 9th Annual Current Trends in Mining Finance Conference, where he emphasized the crucial importance of the mining industry to modern civilization and outlined a strategic approach to improving […]
August 14, 2024 — Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance lidar solutions, is reporting its business and financial results for the second quarter ended June 30, 2024. Highlights of the report included the signing of an agreement and plan of merger for the acquisition by Koito Manufacturing Co. Ltd. (“Koito”), the completion of key milestones […]
August 14, 2024 — SOBRsafe (NASDAQ: SOBR), a provider of next-generation, transdermal alcohol-detection solutions, is reporting on its NASDAQ listing, financial positioning and sales progress, noting that the NASDAQ Hearings Panel granted the company an exception period continuing the listing of its common stock on the NASDAQ exchange; the company has until Oct. 23, 2024, to regain compliance with […]
August 14, 2024 — Mullen Automotive (NASDAQ: MULN), an electric vehicle (“EV”) manufacturer, is providing a financial and business report for the three- and nine-month period ended June 30, 2024. Highlights of the report indicate a positive stockholders’ equity of $53 million and total assets of $192 million. The report also noted, among other key milestones, that the company has secured […]
August 14, 2024 — Mullen Automotive (NASDAQ: MULN), an electric vehicle (“EV”) manufacturer, is providing a financial and business report for the three- and nine-month period ended June 30, 2024. Highlights of the report indicate a positive stockholders’ equity of $53 million and total assets of $192 million. The report also noted, among other key milestones, that the company has secured […]
August 14, 2024 — McEwen Mining (NYSE: MUX) (TSX: MUX), an asset rich diversified gold and silver producer in the Americas with a large exposure to copper through its subsidiary McEwen Copper, released its second-quarter and half-year 2024 financial results for the period ended June 30, 2024, along with key updates regarding the current mining situation in Argentina and […]
August 14, 2024 — McEwen Mining (NYSE: MUX) (TSX: MUX), an asset rich diversified gold and silver producer in the Americas with a large exposure to copper through its subsidiary McEwen Copper, released its second-quarter and half-year 2024 financial results for the period ended June 30, 2024, along with key updates regarding the current mining situation in Argentina and […]
August 14, 2024 — D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software, and services, and the first commercial provider of quantum computers, recently announced a significant increase in enrollment for its quantum training courses. In the first half of 2024, the enrollment numbers saw double-digit growth compared to the same period in 2023 (https://ibn.fm/n5wXd). The “Quantum Programming […]
August 14, 2024 — D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software, and services, and the first commercial provider of quantum computers, recently announced a significant increase in enrollment for its quantum training courses. In the first half of 2024, the enrollment numbers saw double-digit growth compared to the same period in 2023 (https://ibn.fm/n5wXd). The “Quantum Programming […]
August 13, 2024 — Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, just released its fiscal report for the third quarter of the 2024 financial year (“Q3, 2024”). Of note was growth in cash and marketable securities from $1.5 million during the same period in the 2023 financial year to $8.5 million as of May 31, […]
August 13, 2024 — The severe consequences of domestic violence incidents are driving the monitoring of offenders’ whereabouts via electronic GPS-enabled technologies. Tennessee enacted a law last month described as the first in the nation to codify measures statewide requiring electronic GPS monitoring (“EM”) for people arrested for stalking, aggravated stalking or especially aggravated stalking. The law also encompasses […]
August 13, 2024 — Annovis Bio (NYSE: ANVS), a late-stage clinical drug platform company, announced the issuance of a U.S. patent for treating traumatic brain injury (“TBI”) with its lead drug candidate, buntanetap. Initially filed in 2016, the patent covered treatments for various nerve injuries, including TBI, stroke, and spinal cord injuries, but required division into individual patents by […]
